Table 3.
Variable | OR | 95% CI | P value |
| |||
Sex | |||
| |||
Female (reference) | |||
| |||
Male | 1.15 | 1.13–1.17 | < 0.001 |
| |||
Age-group | |||
| |||
0–18 Years (reference) | |||
| |||
19–39 Years | 1.25 | 1.22–1.28 | < 0.001 |
| |||
40–59 Years | 1.24 | 1.20–1.28 | < 0.001 |
| |||
60+ Years | 0.85 | 0.81–0.90 | < 0.001 |
| |||
Nationality-grouped | |||
| |||
MENA (reference) | |||
| |||
Asian | 1.29 | 1.27–1.32 | < 0.001 |
| |||
African | 0.90 | 0.84–0.96 | < 0.001 |
| |||
Others | 0.55 | 0.52–0.58 | < 0.001 |
| |||
Symptoms presentation | |||
| |||
Asymptomatic (reference) | |||
| |||
Symptomatic | 4.52 | 4.42–4.64 | < 0.001 |
|